XML 28 R17.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

6 Months Ended

Jun. 30, 2020

Equity [Abstract]

Stockholders' Equity

9. Stockholders’ Equity

Common Stock

The Company has the authority to issue 1,000,000,000 shares of common stock, $0.01 par value per share (further details as of the date these condensed consolidated financial statements were issued or were available to be issued are provided under the heading Amendment to Certificate of Incorporation in Note 13).

Common Stock Warrants

The Company issued warrants to purchase shares of the Company’s common stock to MDB Capital Group, LLC (the “MDB Warrants”), L2 Capital, LLC (the “L2 Warrants”), Strome Mezzanine Fund LP (the “Strome Warrants”), and B. Riley Financial, Inc. (the “B. Riley Warrants”) in connection with various financing transactions (collectively, the “Financing Warrants”).

The Financing Warrants outstanding and exercisable as of June 30, 2020 are summarized as follows:

									Outstanding
		Exercise Price				Expiration Date			Classified as Derivative Liabilities (Shares)				Classified within Stockholders’ Equity (Shares)				Total Exercisable (Shares)
MDB Warrants		$	0.20			November 4, 2021				-				327,490				327,490
Strome Warrants			0.50			June 15, 2023				1,500,000				-				1,500,000
B. Riley Warrants			1.00			October 18, 2025				875,000				-				875,000
MDB Warrants			1.15			October 19, 2022				-				119,565				119,565
MDB Warrants			2.50			October 19, 2022				-				60,000				60,000
Total outstanding and exercisable										2,375,000				507,055				2,882,055

The intrinsic value of exercisable but unexercised in-the-money stock warrants as of June 30, 2020 was $372,371, based on a fair market value of the Company’s common stock of $0.65 per share on June 30, 2020.